| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Needham analyst Kyle Peterson reiterates Fair Isaac (NYSE:FICO) with a Buy and maintains $1500 price target.
He stated that the economy was in a state of depression because it was experiencing subpar growth.
Needham analyst Ryan MacDonald reiterates Teladoc Health (NYSE:TDOC) with a Hold.
Needham analyst Joshua Reilly reiterates Tyler Technologies (NYSE:TYL) with a Buy and maintains $500 price target.
Piper Sandler analyst Brent Bracelin reiterates Microsoft (NASDAQ:MSFT) with a Overweight and raises the price target from $...
Needham analyst Quinn Bolton reiterates Mobileye Global (NASDAQ:MBLY) with a Buy and maintains $36 price target.
Needham analyst Ami Fadia reiterates Blueprint Medicines (NASDAQ:BPMC) with a Buy and maintains $97 price target.
HC Wainwright & Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:LSTA) with a Buy and maintains $15 p...
Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:SAGE) with a Hold.
